Recursion Pharmaceuticals (RXRX.US) Stock Community - Hot Topic Discussions - Longbridge

Quote List Quote List

Event Tracking

Dec9

Recursion Pharmaceuticals Shares Show Initial Rebound, Undervalued and Advised for Exploration of Investment Opportunities

06:08

Dec8

Recursion Pharma's Drug REC-4881 Shows Promising Results in Clinical Trials

12:30

Dec6

Recursion Pharmaceuticals CEO Announces Sale of Common Stock

00:20

Dec4

Blake Borgeson reports disposal of Recursion Pharmaceuticals common stock

21:52

Dec1

Recursion Pharmaceuticals to Release New Data on REC-4881 for Familial Adenomatous Polyposis

13:30

Nov26

Recursion Pharmaceuticals Issues Shares to Tempus AI

13:13

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 5.175 M, Net Income -162.25 M, EPS -0.3629

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 19.22 M, Net Income -171.9 M, EPS -0.4118

May5

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 14.75 M, Net Income -202.49 M, EPS -0.5027

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More